Cargando…

IBD in the time of corona — vigilance for immune-mediated diseases

The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of...

Descripción completa

Detalles Bibliográficos
Autor principal:	Moschen, Alexander R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301345/ https://www.ncbi.nlm.nih.gov/pubmed/32555385 http://dx.doi.org/10.1038/s41575-020-0333-5

Ejemplares similares

Urology in the time of corona
por: Naspro, Richard, et al.
Publicado: (2020)

Remaining vigilant about COVID-19 and suicide
por: Botchway, Stella, et al.
Publicado: (2021)

Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022)

Time to be vigilant in contacts of leprosy for possible single-dose rifampicin
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)

Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD
por: Otten, Antonius T, et al.
Publicado: (2023)

Moving towards more patient-centred clinical trials in IBD
por: Noor, Nurulamin M., et al.
Publicado: (2021)

Innovations to improve the efficiency of phase II IBD clinical trials
por: Noor, Nurulamin M., et al.
Publicado: (2023)

Notes on corona crisis and temporality
por: Antentas, Josep Maria
Publicado: (2020)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

Management of IBD during the COVID-19 outbreak: resetting clinical priorities
por: Danese, Silvio, et al.
Publicado: (2020)

The day after COVID-19 in IBD: how to go back to ‘normal’
por: Danese, Silvio, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in IBD: more pros than cons
por: D’Amico, Ferdinando, et al.
Publicado: (2021)

The need for improved methodology in protein corona analysis
por: Mahmoudi, Morteza
Publicado: (2022)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

CoronaVac: more data for regulators and policy makers
por: Ramasamy, Maheshi N, et al.
Publicado: (2021)

Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD
por: Klepsch, Victoria, et al.
Publicado: (2019)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine
por: Oshiro, Telma Miyuki, et al.
Publicado: (2022)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
por: Boekel, Laura, et al.
Publicado: (2022)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Not just antibodies: B cells and T cells mediate immunity to COVID-19
por: Cox, Rebecca J., et al.
Publicado: (2020)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

Predictive genetic testing for Motor neuron disease: time for a guideline?
por: McNeill, Alisdair, et al.
Publicado: (2022)

Remote tissue immune priming in allergic disease
por: Ubags, Niki D.
Publicado: (2020)

Time perception at different EEG-vigilance levels
por: Minkwitz, Juliane, et al.
Publicado: (2012)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

Monkeypox infection creates immune signatures of disease progression
por: Kennedy, Rick B
Publicado: (2023)

Takotsubo Syndrome: Latest Addition to the Expanding Family of Immune-Mediated Diseases?
por: Sattler, Susanne, et al.
Publicado: (2018)

IBD in the Time of COVID19
por: Moss, Alan, et al.
Publicado: (2020)

Climate change and infectious disease: time for a new normal?
por: Heffernan, Claire
Publicado: (2015)

Disease surveillance for the COVID-19 era: time for bold changes
por: Morgan, Oliver W, et al.
Publicado: (2021)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Eternal Vigilance
Publicado: (1900)

Thyroid Vigilance
por: Kalra, Sanjay, et al.
Publicado: (2017)

The compartmentalized upper respiratory mucosa needs time to rally a sufficient immune force for SARS-CoV-2 clearance
por: Zheng, Xiaowen, et al.
Publicado: (2022)

Early life immunity in the era of systems biology: understanding development and disease
por: Schaffert, Steven, et al.
Publicado: (2018)

Role of immunity landscape in global risk assessment of re-emerging diseases
por: Pandey, Abhishek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rg198drauea7p8l5bkh0or9dns